Home
Science
Therapeutic Strategy
Team
News
Contact

Contact

Recent Posts

Visgenx to Present at the 4th Annual Dry AMD Therapeutic Development Summit
Visgenx Announces Issuance of a U.S. Patent Claiming Compositions of Candidate ELOVL2 Gene Therapy
Visgenx Poster: Advancing Next Generation Therapies, West Coast Symposium
Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation Therapies, West Coast Symposium
Visgenx Announces Positive Results from a Key Translational Study for its Gene Therapy Candidate for Dry AMD

Archives

November 2023
October 2023
September 2023
June 2023
May 2023

Categories

Uncategorized

Archives

November 2023
October 2023
September 2023
June 2023
May 2023

Author: madeline

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Visgenx, Inc. © 2023. All Rights Reserved.

Privacy Policy Terms of Use

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy